Skip to content
Buy This GLP
← Research
Evidence

Do GLP-1 Drugs Help Binge Eating? What Trials Found

Binge-eating scores fell on average in nine randomized trials. Evidence for treating diagnosed binge-eating disorder remains limited.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team4 min read
25 randomized trials in the review8,069 participants across eating outcomesNine trials measured binge eating2,106 participants contributed to that estimate

GLP-1 drugs may reduce binge-eating symptoms, but evidence for treating diagnosed binge-eating disorder remains limited. Reports of less food noise during semaglutide treatment describe thoughts and preoccupation with food. Clinical trials can measure a different outcome, such as how often people have binge episodes.[1][2]

What the larger review found

The 2026 review included 25 randomized trials with 8,069 participants across several eating-related outcomes. Nine trials with 2,106 participants contributed to the binge-eating estimate. The standardized difference favored GLP-1 drugs (Hedges’ g −0.23, 95% CI −0.36 to −0.10). Because the measure combines different scales, it cannot tell you how many fewer binge episodes to expect.[1]

The studies also reported less loss of control over eating and more cognitive or dietary restraint. The review could not determine whether that added restraint was harmful. The authors found substantial differences across studies and called for longer, adequately powered trials in people with diagnosed binge-eating disorder.[1]

What a trial in diagnosed binge-eating disorder found

In a 17-week pilot trial, the analysis included 27 adults with binge-eating disorder. Weekly binge episodes decreased in both groups, and the difference between liraglutide and placebo was not statistically significant. The researchers identified a pharmacy dispensing error as a major limitation. The trial illustrates why changes in eating behavior and changes in body weight need to be measured separately.[3]

Frequently asked

Do GLP-1 drugs help binge eating?
A 2026 analysis of nine randomized trials found lower binge-eating scores on average. The evidence does not yet establish how well GLP-1 medications treat diagnosed binge-eating disorder over the long term.
Is food noise the same as binge-eating disorder?
Food noise describes persistent thoughts about food. Binge-eating disorder is a clinical diagnosis involving recurrent episodes of eating with loss of control, among other criteria.

Sources

  1. [1] Emptage I, Kozmér S, Cobham-Wilson A, et al. (2026). The effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on binge eating in patients with obesity: a systematic review and meta-analysis eClinicalMedicine. PMID 42666688
  2. [2] Arnaut T, Duncan S, Faurby M, et al. (2026). Retrospective Assessment of Food Noise Changes After Initiation of Injectable Semaglutide for Weight Management in the USA: The INFORM Survey Advances in Therapy. PMID 42217114
  3. [3] Allison KC, Chao AM, Sy AM, et al. (2023). A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder Obesity Science & Practice. Source
  4. [4] U.S. Food and Drug Administration (2026). Vyvanse prescribing information Drugs@FDA. Source
  5. [5] World Psychiatry modified Delphi study group (2026). Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study World Psychiatry. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence